arrow
E

Ella Ariza-Heredia

MD Anderson Cancer Center
H指数:32
被引数:2,965

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients

IDSA 2025年关于在免疫抑制患者中预防季节性COVID-19、流感及RSV感染的疫苗使用指南

2026-03-020
PRE
An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant

对一例异基因造血细胞移植巨细胞病毒血清学阳性受者中进行Letermovir预防的III期、随机、安慰剂对照试验中巨细胞病毒特异性细胞介导免疫的分析

2025-12-010
PRE
The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis

同种异基因造血细胞移植后,在主要巨细胞病毒(CMV)预防时代,爱泼斯坦-巴尔病毒(Epstein-Barr Virus)与巨细胞病毒(Cytomegalovirus)再激活的相互作用

2025-08-250
PRE
Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study

免疫效应细胞治疗后针对白喉、破伤风和肺炎球菌的体液免疫和抗体反应: 一项前瞻性研究

2024-09-190
OAAI
Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes
2024-07-183
OAAI
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience
2024-06-011
PRE
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
2023-07-227
OAAI
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma
2020-07-30111
OAAI
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients A Phase 2, Randomized Clinical Trial
2020-03-0351
OAAI
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study

异基因造血干细胞移植后巨细胞病毒 (CMV) 细胞介导的免疫和CMV感染: REACT研究

2020-02-2071
OAAI